Nutex Health (NUTX) EPS (Weighted Average and Diluted) (2012 - 2026)

Nutex Health has disclosed EPS (Weighted Average and Diluted) across 12 years of filings, most recently posting $6.52 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at $6.52, up 95.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.94 (up 2.21% YoY), and the FY2025 annual result was $10.48, up 8.15% from the prior year.
• EPS (Weighted Average and Diluted) came in at $6.52 for Q1 2026 at Nutex Health, up from $1.61 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $11.12 in Q4 2024 to a low of -$7.47 in Q4 2023.
• The 5-year median for EPS (Weighted Average and Diluted) is -$0.07 (2024), against an average of $0.9.
• Across the five-year window, EPS (Weighted Average and Diluted) slumped 37250.0% in 2023 and surged 4262.5% in 2025, its largest moves.
• Nutex Health's EPS (Weighted Average and Diluted) stood at -$0.02 in 2022, then plunged by 37250.0% to -$7.47 in 2023, then surged by 248.86% to $11.12 in 2024, then tumbled by 85.52% to $1.61 in 2025, then jumped by 304.97% to $6.52 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $6.52 (Q1 2026), $1.61 (Q4 2025), and $7.76 (Q3 2025), per Business Quant data.